Zacks Small Cap Research on MSN

NNVC: Getting Set for Phase 2 Trial of NV-387 in MPox…

NNVC READ THE FULL NNVC RESEARCH REPORT Business Update Mpox Trial to Initiate in Late 2025/Early 2026 NanoViricides, Inc. (NYSE:NNVC) is planning to initiate a Phase 2 clinical trial for the ...